Hu Jing, Yang Yanan, Fu Shaoting, Yu Xiaohan, Wang Xiaohui
School of Exercise and Health, Shanghai University of Sport, Shanghai, China.
School of Exercise and Health, Shanghai University of Sport, Shanghai, China; Department of Kinesiology, College of Physical Education, Shanghai Normal University, Shanghai, China.
Biochim Biophys Acta Mol Basis Dis. 2025 Oct;1871(7):167926. doi: 10.1016/j.bbadis.2025.167926. Epub 2025 May 24.
Exercise alleviates high fat diet (HFD)-induced glycolipid metabolism disorders, but the mechanisms are not discovered totally. Low androgen/androgen receptor (AR) levels are associated with glycolipid metabolism disorders in males, and androgen/AR modulate glycolipid metabolism-related regulators such as peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC1-α), Forkhead box O1 (FoxO1), phosphoenolpyruvate carboxy kinase (PEPCK) and stearyl-coenzyme A desaturase 1 (SCD1). In the present study, we blockaded androgen (by castration) and inhibited or activated AR activity (by AR antagonist flutamide and agonist S4, respectively) to clarify androgen/AR's roles in exercise-induced alleviation of glycolipid metabolism disorders in male high fat diet (HFD) feeding mice and the underlying mechanisms. We found that: (1) exercise reversed HFD-induced glycolipid metabolism disorders, including restoring fasting blood glucose (FBG), glucose tolerance, TC and TG, accompanied with the increases of serum testosterone and AR in muscle and liver. (2) castration exacerbated HFD-induced impairment of glucose tolerance and increases of TC and TG, and abolished the lowering effect of exercise on FBG and TC. Flutamide further impaired glucose tolerance, increased plasm LDL content, and attenuated exercise-induced improvements of FBG and TG content. (3) exercise reduced the levels of FoxO1 and SCD1, increased PGC-1α in muscle and liver of HFD mice; whereas castration and flutamide reversed exercise-induced improvements of these indicators. Furthermore, S4 rectified the levels of FoxO1, PGC-1α and SCD1 in HFD mice even in absence of androgen. In conclusion, androgen/AR, especially AR, play important roles in alleviating glycolipid metabolism disorders in HFD mice at sedentary and exercise states, which might fulfill through FOXO1, PGC-1α and SCD1.
运动可缓解高脂饮食(HFD)诱导的糖脂代谢紊乱,但其机制尚未完全明确。男性体内雄激素/雄激素受体(AR)水平降低与糖脂代谢紊乱有关,且雄激素/AR可调节糖脂代谢相关调节因子,如过氧化物酶体增殖物激活受体γ辅激活因子1α(PGC1-α)、叉头框蛋白O1(FoxO1)、磷酸烯醇式丙酮酸羧激酶(PEPCK)和硬脂酰辅酶A去饱和酶1(SCD1)。在本研究中,我们通过去势阻断雄激素,并分别使用AR拮抗剂氟他胺和激动剂S4抑制或激活AR活性,以阐明雄激素/AR在运动诱导的雄性高脂饮食(HFD)喂养小鼠糖脂代谢紊乱缓解中的作用及潜在机制。我们发现:(1)运动可逆转HFD诱导的糖脂代谢紊乱,包括恢复空腹血糖(FBG)、糖耐量、总胆固醇(TC)和甘油三酯(TG),同时肌肉和肝脏中血清睾酮和AR水平升高。(2)去势加剧了HFD诱导的糖耐量损害以及TC和TG升高,并消除了运动对FBG和TC的降低作用。氟他胺进一步损害糖耐量,增加血浆低密度脂蛋白含量,并减弱运动诱导的FBG和TG含量改善。(3)运动降低了HFD小鼠肌肉和肝脏中FoxO1和SCD1水平,增加了PGC-1α水平;而去势和氟他胺则逆转了运动诱导的这些指标改善。此外,即使在没有雄激素的情况下,S4也能纠正HFD小鼠中FoxO1、PGC-1α和SCD1的水平。总之,雄激素/AR,尤其是AR,在缓解久坐和运动状态下HFD小鼠的糖脂代谢紊乱中起重要作用,这可能是通过FOXO1、PGC-1α和SCD1实现的。